John Radford Selected Research

John Radford Research Topics

Disease

31	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 10/2005
17	Neoplasms (Cancer) 03/2024 - 01/2003
17	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 12/2012
12	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 06/2008
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2023 - 06/2008
7	Lymphoma (Lymphomas) 01/2023 - 12/2012
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 06/2008
5	Disease Progression 02/2023 - 01/2013
5	Neutropenia 01/2023 - 03/2016
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 11/2010
4	Infections 10/2018 - 08/2015
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2018 - 09/2010
3	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2022
3	Cardiotoxicity 11/2023 - 07/2014
3	Left Ventricular Dysfunction 11/2023 - 07/2014
3	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 12/2015
3	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019 - 09/2010
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2018 - 09/2010
2	Febrile Neutropenia 01/2022 - 01/2018
2	Nausea 01/2021 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2021 - 03/2016
2	Fatigue 01/2021 - 01/2021
1	Hypophosphatemia 01/2023
1	Heart Failure 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2021
1	Frailty 01/2021
1	Edema (Dropsy) 01/2021
1	Exanthema (Rash) 01/2021
1	Dental Caries (Decay, Dental) 01/2020
1	Sepsis (Septicemia) 05/2018
1	Enteropathy-Associated T-Cell Lymphoma 05/2018

Drug/Important Bio-Agent (IBA)

15	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 07/2014
14	Rituximab (Mabthera)FDA Link 02/2023 - 11/2008
14	Brentuximab VedotinIBA 10/2022 - 04/2013
9	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 09/2014
9	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 09/2014
8	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 09/2014
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2012
6	loncastuximab tesirineIBA 08/2023 - 12/2019
5	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2018
5	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 02/2014
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 02/2014
4	Lenalidomide (CC 5013)FDA Link 02/2023 - 03/2016
4	ibrutinibIBA 02/2023 - 08/2013
4	pembrolizumabIBA 01/2023 - 07/2017
4	Monoclonal AntibodiesIBA 01/2021 - 06/2008
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 08/2013
4	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 02/2014
4	ofatumumab FDA Link 02/2017 - 06/2008
3	AnthracyclinesIBA 11/2023 - 02/2014
3	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
3	axicabtagene ciloleucelIBA 01/2023 - 01/2022
2	candesartanIBA 11/2023 - 01/2022
2	Carvedilol (Coreg)FDA LinkGeneric 11/2023 - 01/2022
2	Troponin IIBA 11/2023 - 01/2022
2	TroponinIBA 11/2023 - 01/2022
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2018
2	Bendamustine Hydrochloride FDA Link 10/2018 - 12/2017
2	obinutuzumabIBA 10/2018 - 08/2013
2	Cisplatin (Platino)FDA LinkGeneric 05/2018 - 02/2017
2	Gemcitabine FDA Link 05/2018 - 02/2014
2	Inotuzumab OzogamicinIBA 01/2018 - 01/2015
2	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2017 - 09/2014
2	ibritumomab tiuxetan (Zevalin)FDA Link 06/2013 - 11/2008
2	Yttrium-90IBA 06/2013 - 11/2008
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	Syk KinaseIBA 01/2023
1	Amylases FDA Link 01/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 01/2021
1	tirabrutinibIBA 01/2021
1	avelumabIBA 01/2021
1	idelalisibIBA 01/2021
1	NivolumabIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	EnzymesIBA 01/2021
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	tazemetostatIBA 11/2020
1	FluoridesIBA 01/2020
1	acalabrutinibIBA 01/2020
1	silver diamine fluorideIBA 01/2020
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 12/2019
1	Alemtuzumab (Campath)FDA Link 01/2019
1	Prednisone (Sone)FDA LinkGeneric 10/2018
1	GalliumIBA 10/2018
1	Methylprednisolone FDA LinkGeneric 05/2018
1	Anaplastic Lymphoma KinaseIBA 05/2018
1	C-Reactive ProteinIBA 05/2018

Therapy/Procedure

29	Therapeutics 11/2023 - 07/2004
26	Drug Therapy (Chemotherapy) 11/2023 - 01/2003
9	Stem Cell Transplantation 02/2023 - 12/2012
9	Radiotherapy 01/2023 - 01/2003
5	Transplantation 01/2022 - 07/2004
4	Aftercare (After-Treatment) 12/2015 - 01/2003
3	Salvage Therapy 01/2021 - 02/2017
2	Homologous Transplantation 12/2017 - 04/2013
1	Immunotherapy 01/2018